View in EDS HTML Full Text PDF Full Text

iPSC-based drug discovery identified the Hippo signaling pathway as a therapeutic target in the fibrosis of NPHP1-deficient nephronophthisis.

Saved in:
Bibliographic Details
Title: iPSC-based drug discovery identified the Hippo signaling pathway as a therapeutic target in the fibrosis of NPHP1-deficient nephronophthisis.
Authors: Suzuki, Takefumi1 (AUTHOR), Susa, Koichiro1 (AUTHOR) ksusa.kid@tmd.ac.jp, Kikuchi, Hiroaki1 (AUTHOR), Nakano, Yuta1 (AUTHOR), Yanagi, Tomoki1 (AUTHOR), Hara, Yu1 (AUTHOR), Fujiki, Tamami1 (AUTHOR), Ando, Fumiaki1 (AUTHOR), Mandai, Shintaro1 (AUTHOR), Mori, Yutaro1 (AUTHOR), Mori, Takayasu1 (AUTHOR), Iwasa, Hiroaki2 (AUTHOR), Hata, Yutaka3 (AUTHOR), Uchida, Shinichi1 (AUTHOR), Sohara, Eisei1 (AUTHOR) esohara.kid@tmd.ac.jp
Source: Stem Cell Research & Therapy. 9/19/2025, Vol. 16 Issue 1, p1-13. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17576512
DOI:10.1186/s13287-025-04567-0